Chen; Bao-lu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chen; Bao-lu.The latest application filed is for "antagonist anti-cd40 antibody pharmaceutical compositions".

Company Profile

0.17.25

Chen; Bao-lu - San Ramon CA US
Chen; Bao-Lu - Emeryville CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Optimized anti-CD30 antibodies Grant 9,574,006 - Lazar , et al. February 21, 2	2017-02-21
Antagonist Anti-cd40 Antibody Pharmaceutical Compositions App 20150110783 - Lu; Xiaofeng ; et al.	2015-04-23
Antagonist anti-CD40 antibody pharmaceutical compositions Grant 8,945,564 - Lu , et al. February 3, 2	2015-02-03
Antagonist Anti-cd40 Monoclonal Antibodies And Methods For Their Use App 20130011405 - Long; Li ; et al.	2013-01-10
HSA-free formulations of interferon-Beta Grant 8,333,958 - Shirley , et al. December 18, 2	2012-12-18
Antagonist anti-CD40 antibodies Grant 8,277,810 - Long , et al. October 2, 2	2012-10-02
Optimized anti-CD30 antibodies Grant 7,973,136 - Lazar , et al. July 5, 2	2011-07-05
Hsa-free Formulations Of Interferon-beta App 20110104116 - Shirley; Bret A. ; et al.	2011-05-05
HSA-free formulations of interferon-.beta. Grant 7,892,531 - Shirley , et al. February 22, 2	2011-02-22
Stabilized liquid polypeptide-containing pharmaceutical compositions Grant 7,807,142 - Chen , et al. October 5, 2	2010-10-05
Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteins Grant 7,659,248 - Chen , et al. February 9, 2	2010-02-09
Antagonist Anti-cd40 Antibody Pharmaceutical Compositions App 20090304706 - Lu; Xiaofeng ; et al.	2009-12-10
Formulation, Solubilization, Purification, and Refolding of Tissue Factor Pathway Inhibitor App 20080281084 - Dorin; Glenn J. ; et al.	2008-11-13
Optimized Anti-Cd30 Antibodies App 20080267976 - Lazar; Gregory Alan ; et al.	2008-10-30
Antagonist Anti-cd40 Monoclonal Antibodies And Methods For Their Use App 20080254026 - Long; Li ; et al.	2008-10-16
HSA-free formulations of interferon-beta App 20080193415 - Shirley; Bret A. ; et al.	2008-08-14
HSA-free formulations of interferon-beta Grant 7,399,463 - Shirley , et al. July 15, 2	2008-07-15
HSA-free formulations of interferon-.beta. Grant 7,371,373 - Shirley , et al. May 13, 2	2008-05-13
Antagonist Anti-Cd40 Monoclonal Antibodies and Methods for Their Use App 20080057070 - Long; Li ; et al.	2008-03-06
Methods for pulmonary delivery of interleukin-2 App 20080003294 - Chen; Bao-Lu ; et al.	2008-01-03
Optimized Anti-cd30 Antibodies App 20070166309 - Lazar; Gregory Alan ; et al.	2007-07-19
Optimized anti-CD30 antibodies App 20070148171 - Lazar; Gregory Alan ; et al.	2007-06-28
Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor Grant 7,226,757 - Dorin , et al. June 5, 2	2007-06-05
Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants App 20060159679 - Chen; Bao-Lu ; et al.	2006-07-20
Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor App 20060128947 - Dorin; Glenn J. ; et al.	2006-06-15
Stabilized liquid polypeptide-containing pharmaceutical compositions App 20060093576 - Chen; Bao-Lu ; et al.	2006-05-04
Stabilized liquid polypeptide-containing pharmaceutical compositions App 20060093598 - Chen; Bao-Lu ; et al.	2006-05-04
Stabilized liquid polypeptide-containing pharmaceutical compositions Grant 7,030,086 - Chen , et al. April 18, 2	2006-04-18
Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteins App 20060079459 - Chen; Bao-Lu ; et al.	2006-04-13
Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor Grant 7,022,672 - Dorin , et al. April 4, 2	2006-04-04
HSA-free formulations of interferon-beta App 20050142110 - Shirley, Bret A. ; et al.	2005-06-30
HSA-free formulations of interferon-beta Grant 6,887,462 - Shirley , et al. May 3, 2	2005-05-03
Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteins App 20040224886 - Chen, Bao-Lu ; et al.	2004-11-11
HSA-free formulations of interferon-beta App 20040191219 - Shirley, Bret A. ; et al.	2004-09-30
Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants App 20040180827 - Chen, Bao-Lu ; et al.	2004-09-16
Methods for pulmonary delivery of interleukin-2 App 20030198602 - Chen, Bao-Lu ; et al.	2003-10-23
Stabilized liquid polypeptide-containing pharmaceutical compositions App 20030180253 - Chen, Bao-Lu ; et al.	2003-09-25
Stabilized liquid polypeptide-containing pharmaceutical compositions Grant 6,525,102 - Chen , et al. February 25, 2	2003-02-25
HSA- free formulations of interferon-beta App 20020172661 - Shirley, Bret A. ; et al.	2002-11-21
Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor App 20020137884 - Dorin, Glenn J. ; et al.	2002-09-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.